HomeNewsOpinionInterview | Sky is the limit for the growth of our core business, says Sunil Chari, MD of Rossari Biotech

Interview | Sky is the limit for the growth of our core business, says Sunil Chari, MD of Rossari Biotech

Moneycontrol Opinion • November 25, 2020 / 12:29 IST

Rossari Biotech is confident of doubling sales in 3-4 years, and the home and personal care category is expected to comprise over half of the company's revenues in the coming quarters, says its co-founder and MD

To read the full story,

Are you a PRO subscriber? Sign In

Ad free Experience

Seamless navigation, faster responses.
Expert Perspective

Explore 230+ exclusive editorials every month
+

Uncover Insights from World-Renowned Experts and Journalists
Actionable Insights

40+ weekly investment ideas + 3 to 4 daily technical calls
Virtual Events

Exclusive Live Webinars for Expert Trading & Investment Strategies!
Newsletters

Stay ahead with daily and weekly insights

Unlock exclusive discounts